EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Latin American consensus on tapering of biological therapy in psoriasis

Angela María Londoño-García, Juan Raúl Castro-Ayarza, Manuel Darío Franco Franco, Cesar Fernando González Ardila, Gabriel Magariños, Enrique Salvador Rivas Zaldívar, Susan Martínez, Linda Ibatá, Julieth Carolina Castillo, Paola Jimena Cárdenas Rojas, Evelyn Giuliana Castro Vargas, Claudia Romina Contreras und 9 weitere

Anais Brasileiros de Dermatologia · 2025

DOI: 10.1016/j.abd.2025.501134 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Anais Brasileiros de Dermatologia, 2025. Verfasst von Angela María Londoño-García und 20 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Postgraduate Program, Faculty of Medicine, CES University, Medellin, Colombia. Electronic address: alondonog@ces.edu.co. Hauptthemen laut MEDLINE: Psoriasis, Biological Products, Biological Therapy, Dermatologic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Latin American Psoriasis Society, Colombian Group of Psoriasis and Immunodermatology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biologic therapy is an effective psoriasis treatment. However, its long-term use carries the risk of serious adverse effects and high costs for the healthcare system, which is particularly relevant in resource-limited Latin American countries. Therefore, there is scientific interest in exploring the feasibility of tapering therapy in low disease activity or clinical remission.

Objective

To provide expert consensus-based recommendations to guide personalized and efficient tapering of biologic agents in adult patients with cutaneous psoriasis.

Methods

Following an exhaustive systematic literature review, a consensus was developed using a modified Delphi methodology by a group of Latin American clinical dermatologists and an independent methodological team. The topics covered include treatment goals, tapering objectives and strategies, regimens, monitoring and tapering failure, and implementation considerations in patients with psoriasis treated with biological agents.

Results

The expert panel reached a consensus on five general principles and 13 recommendations for tapering biological therapy for psoriasis. These recommendations provide scientific support for dermatologists and healthcare providers regarding criteria for tapering, strategies and regimens, monitoring, failure management, and considerations for implementation.

Conclusion

Tapering of biologics appears to be effective and safe in psoriasis patients with low stable activity or clinical remission. This Latin American consensus was developed in recognition of the need for rational and optimal use of biologics, while individualizing cases to apply best clinical practices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisBiological ProductsBiological TherapyDermatologic AgentsHumansLatin AmericaConsensusDelphi TechniqueTreatment OutcomeDrug Administration Schedule

Stichwörter der Autor:innen

Biological therapyConsensusDelphi techniqueDrug taperingLatin AmericaPsoriasis

Substanzen

Biological ProductsDermatologic Agents

Autor:innen und Institutionen

  • Dermatology Postgraduate Program, Faculty of Medicine, CES University, Medellin, Colombia. Electronic address: alondonog@ces.edu.co.
  • Dermatology Postgraduate Program, Faculty of Medicine, National University of Colombia, Bogota, Colombia.
  • Dermatology Service, Medicarte IPS, Bogota, Colombia.
  • Private Practice, Bogota, Colombia.
  • Dermatology Service, Clinical Practice and Research, Dermatological Medical Center - Psoriahue, Buenos Aires, Argentina.
  • Research Department, Dermatological Medical Center DERMOS, Ciudad de Guatemala, Guatemala.

Förderung

  • Latin American Psoriasis Society
  • Colombian Group of Psoriasis and Immunodermatology

Zitieren

APA

Londoño-García, A. M., Castro-Ayarza, J. R., Franco Franco, M. D., González Ardila, C. F., Magariños, G., Rivas Zaldívar, E. S., Martínez, S., Ibatá, L., Castillo, J. C., Cárdenas Rojas, P. J., Castro Vargas, E. G., Contreras, C. R., de la Cruz Fernández, C., Chavarriaga Restrepo, A., Echeverria, C. M., Esteves de Carvalho, A. V., Hidalgo Matlock, B., Loayza, E., Maskin, M. R., …, & Valenzuela, F. (2025). Latin American consensus on tapering of biological therapy in psoriasis. Anais Brasileiros de Dermatologia. https://doi.org/10.1016/j.abd.2025.501134

Vancouver

Londoño-García AM, Castro-Ayarza JR, Franco Franco MD, González Ardila CF, Magariños G, Rivas Zaldívar ES, et al. Latin American consensus on tapering of biological therapy in psoriasis. Anais Brasileiros de Dermatologia. 2025. doi:10.1016/j.abd.2025.501134

BibTeX
@article{LondooGarca2025,
  author = {Londoño-García, Angela María and Castro-Ayarza, Juan Raúl and Franco Franco, Manuel Darío and González Ardila, Cesar Fernando and Magariños, Gabriel and Rivas Zaldívar, Enrique Salvador and Martínez, Susan and Ibatá, Linda and Castillo, Julieth Carolina and Cárdenas Rojas, Paola Jimena and Castro Vargas, Evelyn Giuliana and Contreras, Claudia Romina and de la Cruz Fernández, Claudia and Chavarriaga Restrepo, Andrés and Echeverria, Cristina Mariela and Esteves de Carvalho, André Vicente and Hidalgo Matlock, Benjamín and Loayza, Enrique and Maskin, Matías Rafael and Romiti, Ricardo and Valenzuela, Fernando},
  title = {Latin American consensus on tapering of biological therapy in psoriasis},
  journal = {Anais Brasileiros de Dermatologia},
  year = {2025},
  doi = {10.1016/j.abd.2025.501134}
}
Kostenlos starten →